A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus
Clinical trial NCT04235959 · COMPLETED
Trial details
- NCT number
- NCT04235959
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-21
- Primary completion
- 2021-08-17
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.